It is commonly believed that allergic sensitization starts when an allergen contacts the surface of an antigen-presenting cell in mucosal or skin epithelia. Most studies dealing with this aspect use allergen extracts as stimulus. Under natural exposure conditions, however, the bioavailability of allergen depends on allergen liberation from internal binding sites within the allergen carrier, e.g. pollen grains. In comparing total protein and major allergen release from timothy grass (Phleum pratense L.) pollen freshly collected on rural meadows or near high-traffic roads, there was a striking difference between the pollen, with higher allergen release rates from rural meadow pollen grains. Thus, allergen release does not explain the higher prevalence rates of atopic sensitization and disease observed in many epidemiological studies in children exposed to automobile exhaust. Therefore, other possible effectors from pollen grains were investigated. Pollen grains incubated in protein- free buffer were found to secrete significant amounts of eicosanoid-like substances, namely leukotriene (LT) B4-like and prostaglandin E2-like substances, in a pH-, time- and temperature-dependent fashion. The highest values of eicosanoid secretion were found in birch, grass and mugwort pollen, while pine (Pinus sylvestris L.) pollen showed only marginal eicosanoid-like secretion. Additionally, the release of these substances was significantly higher from pollen which had been collected near roads with heavy traffic, indicating a stronger proinflammatory activity of these pollen grains. In order to investigate the effects of air pollutants, native pollen grains were exposed in a dose- and time-dependent fashion in a fluidized bed reactor to traffic-related pollutants, e.g. volatile organic compounds (toluene, m-xylene), leading again to a significant increase in the secretion of LTB4-like immunoreactivity, in contrast to exposure with sulfur dioxide. This finding opens a new dimension of understanding of the early events in allergic sensitization, indicating that proinflammatory effects of the allergen carrier, e.g. the pollen grain itself, can lead to activation of the mucosal membrane. These findings might help to also explain the higher prevalence rates of pollen allergy in areas with high automobile exhaust emissions. Furthermore, the allergenic ‘potency’ of various allergens has to be redefined at the allergen carrier level with regard to different stages of allergen and mediator release prior to the contact with the host’s immune system.

Keywords:
Pollen, Eicosanoid-like substances, Air pollution, Allergy
1.
Burney PGJ, Luczynska C, Chinn S, Jarvis D: The European Community Respiratory Health Survey. Eur Respir J 1994;7:954–960.
2.
Burr ML (ed): Epidemiology of Allergic Diseases. Basel, Karger, 1993.
3.
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225–1232.
4.
Wüthrich B: Epidemiology of the allergic diseases: Are they really on the increase? Int Arch Allergy Appl Immunol 1989;90:3–10.
5.
Behrendt H, Becker WM, Friedrich KH, Darsow U, Tomingas R: Interaction between aeroallergens and airborne particulate matter. Int Arch Allergy Immunol 1992;99:425–428.
6.
Behrendt H, Friedrichs KH, Krämer U, Hitzfeld B, Becker WM, Ring J: The role of indoor and outdoor air pollution in allergic diseases. Prog Allergy Clin Immunol 1995;3:83–89.
7.
Miyamoto T, Takafuji S: Environment and allergy; in Ring J, Przybilla B (eds): New Trends in Allergy III. Berlin, Springer, 1991, pp 459–468.
8.
Rusnak C: The impact of pollution on allergic disease. Allergy 1994;49:21–27.
9.
Schäfer T, Vieluf D, Behrendt H, Krämer U, Ring J: Atopic eczema and other manifestations of atopy: Results of a study in East and West Germany. Allergy 1996;51:532–539.
10.
Behrendt H, Friedrichs K, Kainka-Staenicke E, Darsow U, Becker WM, Tomingas R: Allergens and pollutants in the air – a complex interaction; in Ring J, Przybilla B (eds): New Trends in Allergy III. Berlin, Springer, 1991, pp 467–478.
11.
Behrendt H, Tomczok J, Sliwa-Tomczok W, Kasche A, Ebner von Eschenbach C, Becker WM, Ring J: Timothy grass (Phleum pratense L.) pollen as allergen carriers and initiators of an allergic response. Int Arch Allergy Immunol 1999;118:414–418.
12.
Schäppi GF, Monn C, Wüthrich B, Wanner HU: Direct determination of allergens in ambient aerosols: Methodological aspects. Int Arch Allergy Immunol 1996;110:364–370.
13.
Spieksma F, Kramps JA, van der Linden AC, Nikkels BH, Plomp A, Koerten HK, Dijkman JH: Evidence of grass pollen allergenic activity in the smaller micronic atmospheric aerosol fraction. Clin Exp Allergy 1990;20:273–280.
14.
Risse U, Tomczok J, Huss-Marp J, Darsow U, Behrendt H: Health-relevant interaction between airborne particulate matter and aeroallergens (pollen). J Aerosol Sci 2000;31(suppl 1):S27–S28.
15.
Kasche A, Risse U, Sliwa-Tomczok W, Tomczok J, Huss-Marp J, Ring J, Behrendt H: Role of polymorphonuclear neutrophils in initiation of allergic sensitization? ACI International 2000(suppl 2):190.
16.
Sass-Kuhn SP, Moqbel R, Mackay JA, Cromwell O, Kay AB: Human granulocyte/pollen-binding protein: Recognition and identification as transferrin. J Clin Invest 1984;73:202–210.
17.
Kowalski ML, Grzegorczyk J, Sliwinska-Kowalska M, Wojciechowska B, Rozniecka M, Rozniecka J: Neutrophil chemotactic activity (NCA) nasal secretions from atopic and nonatopic subjects. Effect of antigen challenge. Allergy 1993;48:409–414.
18.
Krämer U, Koch T, Ranft U, Ring J, Behrendt H: Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology 2000;11:64–70.
19.
Weiland SK, Mundt KA, Rückmann A, Keil U: Self-reported wheezing and allergic rhinitis in children and traffic density on street of residence. Ann Epidemiol 1994;4:243–247.
20.
Ring J: Allergy and modern society: Does ‘Western life style’ promote the development of allergies? Int Arch Allergy Immunol 1997; 113:7–10.
21.
Wichmann H: Environment, life-style and allergy: The German answer. Allergo J 1995;6:315–316.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.